Atlassian Corporation TEAM
Composite 48/100; the shares have moved about 95% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 26/100 — a moderate mark against it.
Momentum ranks 73/100 — a moderate point in its favour. Growth ranks 70/100 — a moderate point in its favour. Balance-sheet strength ranks 52/100 — a slight point in its favour.
Valuation ranks 26/100 — a moderate mark against it. Quality ranks 34/100 — a moderate mark against it.
What the company does Atlassian (TEAM) builds collaboration software—Jira, Confluence, Loom, and AI tools like Rovo—that help teams plan, track, and share work globally. Its portfolio spans project management, developer tools, and enterprise agility solutions like Jira Align and Compass.
Key financials TEAM reports gross margins of 84.8% but net margins of -3.5%, with revenue growth of 31.7% and EPS growth of 172.2%. ROE is -19.3%, ROA 0.5%, and ROCE -6.2%. Debt/Equity is 1.41, net debt/EBITDA 0.61, and interest coverage is -3.32.
Stock health The stock shows mixed momentum: +39.20% over 3 months, -27.19% over 6 months, and -50.95% over 12 months. RSI(14) is 56.40, and it’s down -51.04% from its 52-week high. Sideravia scores TEAM poorly on quality (23.7) but better on growth (54.5).
Price vs fair value The stock trades at a **discount** of 109.10% to our fair-value estimate of 205.15 and a **discount** of 42.38% to the 12-month target of 139.70. - Analysts highlight TEAM’s AI push and GAAP profit targets as potential catalysts (Simply Wall St.). - Momentum-focused outlets cite strong fundamentals despite recent underperformance (StockStory). - Retail investor sentiment suggests Wall Street may be underestimating TEAM’s upside (Insider Monkey).
Looking forward TEAM’s AI pivot (Rovo, Focus) and enterprise agility tools could reframe its long-term story, but execution risks remain given weak profitability metrics. Analysts see potential upside if margins improve and AI adoption accelerates.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.